Editor's Comparative Analysis
When choosing between Endocrine Oncology and ESMO Real World Data and Digital Oncology, researchers should consider the trade-off between prestige (ESMO Real World Data and Digital Oncology leads with an IF of ) and cost-efficiency, as Endocrine Oncology is a Diamond Open Access venue.
Endocrine Oncology is published in GB, while ESMO Real World Data and Digital Oncology is headquartered in GB. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | Endocrine Oncology | ESMO Real World Data and Digital Oncology |
|---|---|---|
| General Information | ||
| Publisher | Bioscientifica | Elsevier |
| Country of Origin | GB | GB |
| Established | 2023 | 2024 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor | N/A | N/A |
| Indexing Status |
DOAJ
|
DOAJ
|
| Review Speed (Decision) |
69 days
Standard
|
87 days
Standard
|
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Full OA | Full OA |
| APC Fee (Estimated) | FREE (Diamond) | $2,750.00 |
Historical Impact Factor Comparison
No historical impact factor data available for these journals yet.
About Endocrine Oncology
Endocrine Oncology is a prominent academic journal specializing in Diseases of the endocrine glands. Clinical endocrinology and Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Published by Bioscientifica in GB, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified …
View Full ProfileAbout ESMO Real World Data and Digital Oncology
ESMO Real World Data and Digital Oncology is a prominent academic journal specializing in Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Published by Elsevier in GB, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 2949-8201. …
View Full ProfileSearching for: Endocrine Oncology impact factor, ESMO Real World Data and Digital Oncology APC fees, journal comparison tool 2026.